Does evidence support extending the duration of intravenous iron dextran (INFeD) infusion in pregnant patients?  

Are there specific safety or efficacy benefits associated with prolonged infusion times in this population?



Answer from: at Community Practice

Answer from: Medical Oncologist at Academic Institution